Jci_page_head_homepage_01 Jci_page_head_homepage_02
Lingwen Zhong, Senta Georgia, Shuen-ing Tschen, Keiko Nakayama, Keiichi Nakayama, Anil Bhushan
Published in Volume 117, Issue 10
J Clin Invest. 2007; 117(10):2869–2876 doi:10.1172/JCI32198
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3
Decreased β cell mass, impaired glucose metabolism, and hypoinsulinemia in Skp2–/– mice.

(A) Analysis of β cell mass of Skp2+/– and Skp2–/– mice at 2 weeks, 10 weeks, and 6 months of age. Values are representative of 5 slides spanning the whole pancreas of each mouse and 3 mice per genotype at each age. (B) Serum insulin levels in Skp2+/– and Skp2–/– mice before and 30 minutes after glucose injection i.p. following overnight fast. n = 3 per group. (C) Glucose tolerance test. Ten-week-old Skp2+/– and Skp2–/– mice were fasted overnight, and the blood glucose level was measured before and after glucose challenge. Differences were significant between groups at 30, 60, and 120 minutes (P < 0.001 for all comparisons). n = 5 (Skp2+/–); 8 (Skp2–/–). *P < 0.05; ***P < 0.005.